Ariceum and UCB link up to take on immune-related diseases
The companies will use proprietary technology to enable the discovery of peptide-radioisotope conjugates
Read More
Tag: immune
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
